Physician profile
Ross William Dodge
NPI 1881850949
$2,335.81
in general payments reported to CMS, 2019-2025
10 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.45 · 2020: $36.37 · 2021: $119 · 2022: $143 · 2023: $1,379 · 2024: $352 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Travel and Lodging: $764 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.33 |
| Travel and Lodging | $764.04 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,700.68 | 2021-2024 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $223.79 | 2025 | Lumryz |
| Itamar Medical INC | $168.08 | 2022-2024 | Watchpatone |
| Lilly USA, LLC | $81.36 | 2024 | Zepbound |
| Arbor Pharmaceuticals, INC. | $45.45 | 2019 | |
| Jazz Pharmaceuticals INC. | $36.37 | 2020 | |
| Abbvie INC. | $26.08 | 2024 | |
| Resmed Corp | $24.13 | 2025 | |
| Axsome Therapeutics, INC. | $16.23 | 2023 | Sunosi |
| Tg Therapeutics, INC. | $13.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Dodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.